Treatment of atopic eczema with oral alitretinoin

Authors


  • Conflicts of interest: M.G. and A.W. have received financial support and S.M., J.C.P. and T.R. have conducted clinical trials with alitretinoin and have received financial support from Basilea Pharmaceuticals GmbH, the manufacturer of oral alitretinoin. However, there was no financial support for the clinical observation submitted here.

Andreas Wollenberg.
E-mail: wollenberg@lrz.uni-muenchen.de

No abstract is available for this article.

Ancillary